[A13-17] Vildagliptin/metformin - Benefit assessment according to § 35a Social Code Book V (dossier assessment)
|Commission:||Commission awarded on 2013-03-28 by the Federal Joint Committee (G-BA)|
|Current document:||Extract of dossier assessment Further documents|
After completion of the assessment by IQWiG the Federal Joint Committee (G-BA) conducts a commenting procedure. This may provide supplementary information and as a result lead to a modified benefit assessment. Further information and the decision on the early benefit assessment can be found on the relevant page of the G-BA website.
|Contact address:||to the contact form|
Addendum to Commission A13-17 (vildagliptin/metformin)
Status: Commission completed
Extract of dossier assessment
Federal Joint Committee (G-BA)
2013-10-01 A G-BA decision was published.